Condition
Esophageal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 22 Esophageal Carcinoma clinical trials that are recruiting, at sites in 10 countries (most in United States (10), China (8), Spain (3)). By phase: Phase 2 (6), Phase 1/2 (2), Phase 3 (2), Early Phase 1 (1). The most active sponsors are Fudan University (2), M.D. Anderson Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 22Clinical trials
- 10Countries
Newest Esophageal Carcinoma clinical trials
All recruiting trials (22)
-
Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread
This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.
-
Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
This study looks at whether surgery improves survival for people with localized small cell esophageal cancer compared with non-surgical treatment.
-
Postoperative Low Oxygen and Chance of Leaks After Esophageal Surgery
This study looks at whether low oxygen levels after esophageal cancer surgery increase the chance of an anastomotic leak.
-
Using the PAGODA algorithm to guide FOLFOX dose changes and reduce unplanned chemotherapy delays
This trial will test whether using the PAGODA algorithm to guide dose changes during FOLFOX chemotherapy for people with gastrointestinal cancers can reduce unplanned treatment delays.
-
Indocyanine green to highlight tumor depth and margins during endoscopic removal of esophageal or stomach cancer
This trial will test whether a dye called indocyanine green can help doctors see the depth and edges of superficial esophageal or stomach cancers during endoscopic submucosal dissection.
-
Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer
This trial will test whether giving local treatment (surgery or radiation) earlier or later after first-line systemic therapy works better for people whose esophageal or stomach cancer has spread to only a few sites.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Radiotherapy followed by immunotherapy for advanced esophageal cancer
This study is testing if a new type of radiation therapy followed by an immune-boosting treatment can help adults with advanced esophageal cancer feel better and improve their health.
-
Prehabilitation with exercise and nutrition before esophagectomy for esophageal cancer
This program will test if exercise plus nutrition before esophagectomy is doable and acceptable for adults with esophageal cancer.
-
Combining immunotherapy with targeted radiotherapy and chemotherapy for advanced esophageal cancer
This study is testing if adding immunotherapy to a combination of targeted radiotherapy and chemotherapy can help people with advanced esophageal cancer feel better and improve their treatment results.
-
Imaging study using two antibody fragments in patients with solid tumors
This study is testing two special antibody fragments in people with solid tumors to see how well they target cancer cells and how they move through the body.
-
Combining Serplulimab with Chemoradiotherapy for Elderly Patients with Advanced Esophageal Cancer
This study is testing if combining a new drug called Serplulimab with standard chemotherapy and radiation can help older patients with advanced esophageal cancer who can't have surgery feel better and live longer.
-
Comparing home and clinic administration of nivolumab for cancer treatment
This study tests whether giving cancer patients their treatment at home instead of in a clinic makes them feel better and prefer their care more.
-
Treatment of Taxane-resistant Cancers with Paclitaxel Polymeric Micelles
This study is testing a new form of chemotherapy called Paclitaxel Polymeric Micelles to see if it can help people with advanced cancers that didn't respond to standard Taxane treatments.
-
Using amiodarone to prevent atrial fibrillation after esophageal cancer surgery
This study is testing if the heart medication amiodarone can help prevent atrial fibrillation in patients recovering from esophageal cancer surgery.
-
Assessing minimal residual disease in esophageal cancer patients
This study is testing how treatment affects leftover cancer cells in patients with advanced esophageal cancer to see if it helps predict how well the treatment is working.
-
Combining postoperative radiotherapy and immunotherapy for advanced esophageal cancer
This study is testing if combining radiation therapy with immunotherapy after surgery can help people with advanced esophageal cancer live longer and have fewer side effects.
-
Evaluating heart damage from radiation in lung and esophageal cancer patients
This study is testing how radiation treatment for lung and esophageal cancer affects the heart and aims to find ways to reduce heart damage during therapy.
-
Observing cancer recurrence using a blood test
This study is testing a new blood test to see if it can help find out if cancer comes back in people who have been treated for early-stage solid tumors.
-
Comparing robot-assisted and open surgery for esophageal cancer
This study is testing if robot-assisted surgery for esophageal cancer is as effective or better than traditional open surgery in helping patients recover and live well after the operation.
-
Yoga intervention to improve physical performance and quality of life for cancer patients and their caregivers
This study tests whether a yoga program can help improve physical performance and quality of life for cancer patients and their caregivers during radiotherapy.
-
Collecting data on side effects of proton therapy for cancer treatment
This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.
Related topics
Quick answers
How many Esophageal Carcinoma clinical trials are recruiting right now?
22, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (10 trials), China (8 trials), Spain (3 trials), Netherlands (3 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 1/2: 2, Phase 3: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.